TWD 75.9
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 13.11 Million TWD | -49.17% |
2022 | 25.8 Million TWD | 299.97% |
2021 | 6.45 Million TWD | -90.77% |
2020 | 69.91 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 9.79 Million TWD | 0.0% |
2024 Q2 | 5.72 Million TWD | 0.0% |
2023 FY | 13.11 Million TWD | -49.17% |
2023 Q3 | 15.49 Million TWD | -18.53% |
2023 Q2 | 19.01 Million TWD | -15.93% |
2023 Q1 | 22.62 Million TWD | 110.64% |
2023 Q4 | 13.11 Million TWD | -15.34% |
2022 Q4 | -212.66 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | 81.791% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | 82.777% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | 96.031% |
TTY Biopharm Company Limited | 403.04 Million TWD | 96.746% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 99.101% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 99.405% |
Center Laboratories, Inc. | 4.42 Billion TWD | 99.704% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -3378.78% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | 95.949% |
InnoPharmax Inc. | 5.38 Million TWD | -143.502% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | 86.993% |
Excelsior Biopharma Inc. | 300.25 Million TWD | 95.632% |
DV Biomed Co., Ltd. | 315.74 Million TWD | 95.846% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -70.969% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 97.375% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -9403.623% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | 76.604% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | 68.525% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | 80.024% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |